Chemomab Therapeutics Ltd DRC (CMMB) Live Share Price, Invest From India

Chemomab Therapeutics Ltd DRC Stock Performance

as on April 25, 2026 at 1:33 am IST

Day's Low
Day's High
$1.62
Day's Price Range
$1.73
$1.66
2.41%
Downside
4.22%
Upside
52 Week's Low
52 Week's High
$1.35
52-Week Price Range
$5.88
$1.66
18.67%
Downside
254.22%
Upside

Chemomab Therapeutics Ltd DRC share price movements today

Previous Close: $1.62
Open: $1.73
Volume: 27.9K
Day's Low - High: $1.62 - $1.73
52 Week Low - High: $1.35 - $5.88

Chemomab Therapeutics Ltd DRC Historical Returns

1 Month Return: + 3.18 %
3 Month Return: -3.57 %
1 Year Return: -68.6 %
3 Year Return: -74.04 %
5 Year Return: -98.81 %

Chemomab Therapeutics Ltd DRC Stock Fundamentals & Key Indicators

Check Chemomab Therapeutics Ltd DRC market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$12.2M

EPS (TTM)

-0.02

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-9.5M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-69.54%

Chemomab Therapeutics Ltd DRC vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Chemomab Therapeutics Ltd DRC with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Chemomab Therapeutics Ltd DRC	BUY	$12.2M	-98.81%	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$41.4B	129.51%	133.3	8.45%
Vertex Pharmaceuticals Inc	BUY	$111.3B	99.68%	28.57	32.94%
BeiGene, Ltd.	NA	$33.3B	NA	121.87	5.37%
Regeneron Pharmaceuticals Inc	BUY	$78.9B	56.77%	17.99	31.41%

Stock Returns calculator for Chemomab Therapeutics Ltd DRC Stock including INR - Dollar returns

The Chemomab Therapeutics Ltd DRC stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Chemomab Therapeutics Ltd DRC investment value today

Current value as on today

₹35,527

Returns

-₹64,473

(-64.47%)

Returns from Chemomab Therapeutics Ltd DRC Stock

-₹67,829 (-67.83%)

Dollar Impact

₹3,357 (+3.36%)

Analyst Recommendation on Chemomab Therapeutics Ltd DRC Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Chemomab Therapeutics Ltd DRC. Average target price of $15

Chemomab Therapeutics Ltd DRC Share Price Target

Get share price movements and forecasts by analysts on Chemomab Therapeutics Ltd DRC.

What analysts predicted

88.93%UPSIDE

Target Price

$15

Current Price

$1.66

Analyzed by

8 Analysts

Target

$15.00

Chemomab Therapeutics Ltd DRC target price $15, a slight upside of 88.93% compared to current price of $1.66. According to 8 analysts rating.

Chemomab Therapeutics Ltd DRC Stock’s Investor Sentiment and Interest

Search interest for Chemomab Therapeutics Ltd DRC Stock has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.

Time period: March 25, 2026 to April 24, 2026

Change:-29% versus previous 30 day period

Chemomab Therapeutics Ltd DRC Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	-	0	-	-	-	0	-	-
Operating Income	-4	-3	-4	-3	-3	-3	-3	-2	-1	-1
EBITDA	-4	-3	-4	-3	-3	-3	-3	-2	-1	-1
Interest Expense	-	-	0	0	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-4	-3	-3	-3	-3	-2	-3	-2	-1	-1
Income Tax Expense	0	0	0	0	-	-	-	-	-	-
Net Income	-4	-3	-3	-3	-3	-2	-3	-2	-1	-1
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Chemomab Therapeutics Ltd DRC Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0
Operating Income	-9	12	27	-5	-12	-28	-25	-14	-9
EBITDA	-9	12	27	-5	-12	-28	-25	-13	-9
Interest Expense	0	-	4	0	0	0	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0
Income Before Tax	-9	12	27	-5	-12	-28	-24	-13	-9
Income Tax Expense	0	0	0	0	0	0	0	-	-
Net Income	-9	13	27	-5	-12	-27	-24	-13	-9
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Chemomab Therapeutics Ltd DRC Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-3	-3	-3	-3	-2	-3	-2	-1	-1
Operating Cash Flow	-3	-	-	-	-	-	-	-	-11
Investing Cash Flow	1	-	-	-	-	-	-	-	5
Financing Cash Flow	2	-	-	-	-	-	-	-	7
Change in Cash	0	-4	0	1	-	2	-2	1	0

Chemomab Therapeutics Ltd DRC Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-9	-13	-27	-11	-12	-27	-24	-14	-9
Operating Cash Flow	-8	-14	-16	-12	-12	-20	-23	-15	-11
Investing Cash Flow	0	0	0	0	-45	19	15	2	5
Financing Cash Flow	5	20	26	0	61	0	3	9	7
Change in Cash	-3	6	10	-12	55	-47	-4	-3	1

Global Institutional Holdings in Chemomab Therapeutics Ltd DRC

Funds	Holdings
Advisory Services Network, LLC	0%

Insights on Chemomab Therapeutics Ltd DRC

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 53.2% return, outperforming this stock by 127.2%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 29.3% return, outperforming this stock by 97.9%
NEGATIVE IMPACT
Price Dip
In the last 1 year, CMMB stock has moved down by -68.6%

About Chemomab Therapeutics Ltd DRC

Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases. Its lead product candidate is nebokitug, a humanized monoclonal antibody that attenuates the basic function of CCL24 as a regulator of major inflammatory and fibrotic pathways, which has completed phase 2 clinical trial for treating primary sclerosing cholangitis, as well as in phase 2 clinical trial to treat systemic sclerosis. The company was founded in 2011 and is based in Tel Aviv-Yafo, Israel.

Organisation	Chemomab Therapeutics Ltd DRC
Headquarters	Building C, Tel Aviv-Yafo, Israel, 6158101
Industry	Biotechnology
CEO	Dr. Adi Mor George Ph.D.
E-voting on shares	Click here to vote

Key Management of Chemomab Therapeutics Ltd DRC

Name	Title
Mr. Jack Lawler	Chief Development Officer
Dr. David M. Weiner M.B.A., M.D.	Interim Chief Medical Officer
Dr. Adi Mor George Ph.D.	Co-Founder, Chief Scientific Officer, CEO & Executive Director
Ms. Sigal Fattal CPA, M.B.A.	Chief Financial Officer

FAQs

What is Chemomab Therapeutics Ltd DRC share price today?

Chemomab Therapeutics Ltd DRC share price today is $1.66 as on April 24, 2026 at 8:03 pm IST. Chemomab Therapeutics Ltd DRC share today touched a day high of $1.73 and a low of $1.62.

What is the 52 week high and 52 week low for Chemomab Therapeutics Ltd DRC share?

Chemomab Therapeutics Ltd DRC share touched a 52 week high of $5.88 on May 20, 2025 and a 52 week low of $1.35 on February 25, 2026. Chemomab Therapeutics Ltd DRC stock price today i.e. April 24, 2026 at 8:03 pm IST is trending at $1.66,which is 71.77% down from its 52 week high and 22.96% up from its 52 week low.

What is Chemomab Therapeutics Ltd DRC's market capitalisation today?

Chemomab Therapeutics Ltd DRC market capitalisation is $0.00T as on April 24, 2026 at 8:03 pm IST.

How to invest in Chemomab Therapeutics Ltd DRC Stock (CMMB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Chemomab Therapeutics Ltd DRC on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Chemomab Therapeutics Ltd DRC Shares that will get you 0.9036 shares as per Chemomab Therapeutics Ltd DRC share price of $1.66 per share as on April 24, 2026 at 8:03 pm IST.

What is the minimum amount required to buy Chemomab Therapeutics Ltd DRC Stock (CMMB) from India?

Indian investors can start investing in Chemomab Therapeutics Ltd DRC (CMMB) shares with as little as ₹94.228 or $1 (as of April 24, 2026 at 8:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹942.28 in Chemomab Therapeutics Ltd DRC stock (as per the Rupee-Dollar exchange rate as on April 24, 2026 at 8:40 pm IST). Based on Chemomab Therapeutics Ltd DRC share’s latest price of $1.66 as on April 24, 2026 at 8:03 pm IST, you will get 6.0241 shares of Chemomab Therapeutics Ltd DRC. Learn more about fractional shares .

What are the returns that Chemomab Therapeutics Ltd DRC has given to Indian investors in the last 5 years?

Chemomab Therapeutics Ltd DRC stock has given -98.81% share price returns and 25.07% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?